CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Mosaic ImmunoEngineering Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.33+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.41M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.7170 (−68.29%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $2.41M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$687.35K
- EPS, diluted
- -$0.08
- Book value per share
- -$1.08
- Diluted shares
- 7M
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Operating income
-$604.01K
Net income
-$687.35K
EPS, diluted
-$0.08
Free cash flow
–
Reported periodTrailing twelve months